Kurt Lippuner

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 916 citations · Full text

Bone Disease, Denosumab Treatment, Bone Health +9

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Dennis M. Black, Ian R. Reid, Steven Boonen et al. · Journal of Bone and Mineral Research · 2011 · 690 citations · Full text

The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation

Paul Lips, D. J. Hosking, Kurt Lippuner et al. · Journal of Internal Medicine · 2006 · 626 citations

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman et al. · New England Journal of Medicine · 2012 · 347 citations · Full text

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

E. Michael Lewiecki, Tomasz Blicharski, Stefan Goemaere et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 301 citations · Full text